By Drug Target Review2025-07-28T08:30:15
Researchers in China have developed a next-generation CAR-T cell therapy armed with nanogels that can penetrate the dense barriers of solid tumours. This addresses a major limitation in the treatment of solid cancers with immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-04-12T15:15:18
Sponsored by Cellistic
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-05-10T11:23:31
Sponsored by BellBrook Labs
Site powered by Webvision Cloud